This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Best peptide telehealth programs: our standard
We do not publish a peptide provider ranking built on marketing claims. This page explains the standard a peptide program must meet to earn a recommendation, and links to the verification tools.
Quick answer
A recommendable peptide program requires licensed clinician oversight, a licensed dispensing pharmacy, honest regulatory disclosure, and evidence-based claims. Until providers clear that bar with verified evidence, we publish the standard rather than a ranking.
Where should you read next?
Verify a peptide provider
Checklist
Peptide therapy overview
How it works
Tesamorelin
An FDA-approved peptide
Sources
- U.S. Food and Drug Administration — approval and compounding status.
- Primary clinical literature cited on child pages.
- Our methodology and source standards.
How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.